The CD27-CD70 pathway and pathogenesis of autoimmune disease

Seminars in Arthritis and Rheumatism

Volumn 45, Issue 4, 2016, Pages 496-501

  Han, Bobby Kwanghoon ^a   Olsen, Nancy J ^b   Bottaro, Andrea ^a  

^a Cooper Medical School of Rowan University ^*  (United States)

^b PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

Autoimmune disease; CD27; CD70; Cytokine

Indexed keywords

CD27 ANTIGEN; CD70 ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; SOLUBLE CD27 ANTIGEN; STRESS ACTIVATED PROTEIN KINASE; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR T BET; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 5; UNCLASSIFIED DRUG;

AUTOIMMUNE DISEASE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; HUMAN; HUMORAL IMMUNITY; INFLAMMATORY BOWEL DISEASE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; NEUROIMMUNOLOGICAL DISEASE; NEUROLOGIC DISEASE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PSORIASIS; REGULATORY T LYMPHOCYTE; REVIEW; RHEUMATOID ARTHRITIS; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; ANIMAL; DISEASE MODEL; IMMUNOLOGY; METABOLISM; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD27; ANTIGENS, CD70; AUTOIMMUNE DISEASES; B-LYMPHOCYTES; DISEASE MODELS, ANIMAL; HUMANS; LYMPHOCYTE ACTIVATION; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 84959478969     PISSN: 00490172     EISSN: 1532866X     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2015.08.001     Document Type: Review

References (77)

1. Lens S.M., Tesselaar K., van Oers M.H., van Lier R.A. Control of lymphocyte function through CD27-CD70 interactions. Semin Immunol 1998, 10:491-499.
2. Agematsu K., Hokibara S., Nagumo H., Komiyama A. CD27: a memory B-cell marker. Immunol Today 2000, 21:204-206.
3. Croft M. Co-stimulatory members of the TNFR family: keys to effective T-cell immunity?. Nat Rev Immunol 2003, 3:609-620.
4. Tortorella C., Schulze-Koops H., Thomas R., Splawski J.B., Davis L.S., Picker L.J., et al. Expression of CD45RB and CD27 identifies subsets of CD4+ memory T cells with different capacities to induce B cell differentiation. J Immunol 1995, 155:149-162.
5. Jacquot S., Kobata T., Iwata S., Morimoto C., Schlossman.S.F. CD154/CD40 and CD70/CD27 interactions have different and sequential functions in T cell-dependent B cell responses: enhancement of plasma cell differentiation by CD27 signaling. J Immunol 1997, 159:2652-2657.
6. Hintzen R.Q., Lens S.M., Koopman G., Pals S.T., Spits H., van Lier R.A. CD70 represents the human ligand for CD27. Int Immunol 1994, 6:477-480.
7. Yang F.C., Agematsu K., Nakazawa T., Mori T., Ito S., Kobata T., et al. CD27/CD70 interaction directly induces natural killer cell killing activity. Immunology 1996, 88:289-293.
8. Takeda K., Oshima H., Hayakawa Y., Akiba H., Atsuta M., Kobata T., et al. CD27-mediated activation of murine NK cells. J Immunol 2000, 164:1741-1745.
9. Wiesmann A., Phillips R.L., Mojica M., Pierce L.J., Searles A.E., Spangrude G.J., et al. Expression of CD27 on murine hematopoietic stem and progenitor cells. Immunity 2000, 12:193-199.
10. Xiao Y., Hendriks J., Langerak P., Jacobs H., Borst J. CD27 is acquired by primed B cells at the centroblast stage and promotes germinal center formation. J Immunol 2004, 172:7432-7441.
11. Loenen W.A., De Vries E., Gravestein L.A., Hintzen R.Q., Van Lier R.A., Borst J. The CD27 membrane receptor, a lymphocyte-specific member of the nerve growth factor receptor family, gives rise to a soluble form by protein processing that does not involve receptor endocytosis. Eur J Immunol 1992, 22:447-455.
12. Kato K., Chu P., Takahashi S., Hamada H., Kipps T.J. Metalloprotease inhibitors block release of soluble CD27 and enhance the immune stimulatory activity of chronic lymphocytic leukemia cells. Exp Hematol 2007, 35:434-442.
13. Tesselaar K., Xiao Y., Arens R., van Schijndel G.M., Schuurhuis D.H., Mebius R.E., et al. Expression of the murine CD27 ligand CD70 in vitro and in vivo. J Immunol 2003, 170:33-40.
14. Kashii Y., Giorda R., Herberman R.B., Whiteside T.L., Vujanovic N.L. Constitutive expression and role of the TNF family ligands in apoptotic killing of tumor cells by human NK cells. J Immunol 1999, 163:5358-5366.
15. Laouar A., Haridas V., Vargas D., Zhinan X., Chaplin D., van Lier R.A., et al. CD70+ antigen-presenting cells control the proliferation and differentiation of T cells in the intestinal mucosa. Nat Immunol 2005, 6:698-706.
16. Sanchez P.J., McWilliams J.A., Haluszczak C., Yagita H., Kedl R.M. Combined TLR/CD40 stimulation mediates potent cellular immunity by regulating dendritic cell expression of CD70 in vivo. J Immunol 2007, 178:1564-1572.
17. Garcia P., De Heredia A.B., Bellon T., Carpio E., Llano M., Caparros E., et al. Signalling via CD70, a member of the TNF family, regulates T cell functions. J Leukoc Biol 2004, 76:263-270.
18. Arens R., Nolte M.A., Tesselaar K., Heemskerk B., Reedquist K.A., van Lier R.A., et al. Signaling through CD70 regulates B cell activation and IgG production. J Immunol 2004, 173:3901-3908.
19. van Lier R.A., Borst J., Vroom T.M., Klein H., Van Mourik P., Zeijlemaker W.P., et al. Tissue distribution and biochemical and functional properties of Tp55 (CD27), a novel T cell differentiation antigen. J Immunol 1987, 139:1589-1596.
20. Akiba H., Nakano H., Nishinaka S., Shindo M., Kobata T., Atsuta M., et al. CD27, a member of the tumor necrosis factor receptor superfamily, activates NF-kappaB and stress-activated protein kinase/c-Jun N-terminal kinase via TRAF2, TRAF5, and NF-kappaB-inducing kinase. J Biol Chem 1998, 273:13353-13358.
21. Ramakrishnan P., Wang W., Wallach D. Receptor-specific signaling for both the alternative and the canonical NF-kappaB activation pathways by NF-kappaB-inducing kinase. Immunity 2004, 21:477-489.
22. June C.H., Bluestone J.A., Nadler L.M., Thompson C.B. The B7 and CD28 receptor families. Immunol Today 1994, 15:321-331.
23. Watts T.H. TNF/TNFR family members in costimulation of T cell responses. Annu Rev Immunol 2005, 23:23-68.
24. Hendriks J., Gravestein L.A., Tesselaar K., van Lier R.A., Schumacher T.N., Borst J. CD27 is required for generation and long-term maintenance of T cell immunity. Nat Immunol 2000, 1:433-440.
25. Hendriks J., Xiao Y., Borst J. CD27 promotes survival of activated T cells and complements CD28 in generation and establishment of the effector T cell pool. J Exp Med 2003, 198:1369-1380.
26. Peperzak V., Xiao Y., Veraar E.A., Borst J. CD27 sustains survival of CTLs in virus-infected nonlymphoid tissue in mice by inducing autocrine IL-production. J Clin Invest 2010, 120:168-178.
27. Peperzak V., Veraar E.A., Xiao Y., Babala N., Thiadens K., Brugmans M., et al. CD8+ T cells produce the chemokine CXCL10 in response to CD27/CD70 costimulation to promote generation of the CD8+ effector T cell pool. J Immunol 2013, 191:3025-3036.
28. Arens R., Tesselaar K., Baars P.A., van Schijndel G.M., Hendriks J., Pals S.T., et al. Constitutive CD27/CD70 interaction induces expansion of effector-type T cells and results in IFNgamma-mediated B cell depletion. Immunity 2001, 15:801-812.
29. Tesselaar K., Arens R., van Schijndel G.M., Baars P.A., van der Valk M.A., Borst J., et al. Lethal T cell immunodeficiency induced by chronic costimulation via CD27-CD70 interactions. Nat Immunol 2003, 4:49-54.
30. van Oosterwijk M.F., Juwana H., Arens R., Tesselaar K., van Oers M.H., Eldering E., et al. CD27-CD70 interactions sensitise naive CD4+ T cells for IL-12-induced Th1 cell development. Int Immunol 2007, 19:713-718.
31. Soares H., Waechter H., Glaichenhaus N., Mougneau E., Yagita H., Mizenina O., et al. A subset of dendritic cells induces CD4+ T cells to produce IFN-gamma by an IL-12-independent but CD70-dependent mechanism in vivo. J Exp Med 2007, 204:1095-1106.
32. Keller A.M., Schildknecht A., Xiao Y., van den Broek M., Borst J. Expression of costimulatory ligand CD70 on steady-state dendritic cells breaks CD8+ T cell tolerance and permits effective immunity. Immunity 2008, 29:934-946.
33. Keller A.M., Xiao Y., Peperzak V., Naik S.H., Borst.J. Costimulatory ligand CD70 allows induction of CD8+ T-cell immunity by immature dendritic cells in a vaccination setting. Blood 2009, 113:5167-5175.
34. Huang J., Jochems C., Anderson A.M., Talaie T., Jales A., Madan R.A., et al. Soluble CD27-pool in humans may contribute to T cell activation and tumor immunity. J Immunol 2013, 190:6250-6258.
35. Coquet J.M., Middendorp S., van der Horst G., Kind J., Veraar E.A., Xiao Y., et al. The CD27 and CD70 costimulatory pathway inhibits effector function of T helper 17 cells and attenuates associated autoimmunity. Immunity 2013, 38:53-65.
36. Coquet J.M., Ribot J.C., Babala N., Middendorp S., van der Horst G., Xiao Y., et al. Epithelial and dendritic cells in the thymic medulla promote CD4+Foxp3+ regulatory T cell development via the CD27-CD70 pathway. J Exp Med 2013, 210:715-728.
37. Xiao Y., Song J.Y., de Vries T.J., Fatmawati C., Parreira D.B., Langenbach G.E., et al. Osteoclast precursors in murine bone marrow express CD27 and are impeded in osteoclast development by CD70 on activated immune cells. Proc Natl Acad Sci U S A 2013, 110:12385-12390.
38. Lens S.M., Drillenburg P., den Drijver B.F., van Schijndel G., Pals S.T., van Lier R.A., et al. Aberrant expression and reverse signalling of CD70 on malignant B cells. Br J Haematol 1999, 106:491-503.
39. Nolte M.A., van Olffen R.W., van Gisbergen K.P., van Lier.R.A. Timing and tuning of CD27-CD70 interactions: the impact of signal strength in setting the balance between adaptive responses and immunopathology. Immunol Rev 2009, 229:216-231.
40. Sanz I., Wei C., Lee F.E., Anolik J. Phenotypic and functional heterogeneity of human memory B cells. Semin Immunol 2008, 20:67-82.
41. Griffin D.O., Holodick N.E., Rothstein T.L. Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+ CD27+ CD43+ CD70. J Exp Med 2011, 208:67-80.
42. Tangye S.G., Good K.L. Human IgM+CD27+ B cells: memory B cells or "memory" B cells?. J Immunol 2007, 179:13-19.
43. Agematsu K., Kobata T., Yang F.C., Nakazawa T., Fukushima K., Kitahara M., et al. CD27/CD70 interaction directly drives B cell IgG and IgM synthesis. Eur J Immunol 1995, 25:2825-2829.
44. Agematsu K., Nagumo H., Oguchi Y., Nakazawa T., Fukushima K., Yasui K., et al. Generation of plasma cells from peripheral blood memory B cells: synergistic effect of interleukin-10 and CD27/CD70 interaction. Blood 1998, 91:173-180.
45. van Montfrans J.M., Hoepelman A.I., Otto S., van Gijn M., Corput L.van de, Weger R.A.de, et al. CD27 deficiency is associated with combined immunodeficiency and persistent symptomatic EBV viremia. J Allergy Clin Immunol 2012, 129:787-793.e6.
46. Salzer E., Daschkey S., Choo S., Gombert M., Santos-Valente E., Ginzel S., et al. Combined immunodeficiency with life-threatening EBV-associated lymphoproliferative disorder in patients lacking functional CD27. Haematologica 2013, 98:473-478.
47. Kobata T., Jacquot S., Kozlowski S., Agematsu K., Schlossman S.F., Morimoto C. CD27-CD70 interactions regulate B-cell activation by T cells. Proc Natl Acad Sci U S A 1995, 92:11249-11253.
48. Dang L.V., Nilsson A., Ingelman-Sundberg H., Cagigi A., Gelinck L.B., Titanji K., et al. Soluble CD27 induces IgG production through activation of antigen-primed B cells. J Intern Med 2012, 271:282-293.
49. Beishuizen C.R., Kragten N.A., Boon L., Nolte M.A., van Lier R.A., van Gisbergen K.P. Chronic CD70-driven costimulation impairs IgG responses by instructing T cells to inhibit germinal center B cell formation through FasL-Fas interactions. J Immunol 2009, 183:6442-6451.
50. Borst J., Hendriks J., Xiao Y. CD27 and CD70 in T cell and B cell activation. Curr Opin Immunol 2005, 17:275-281.
51. Denoeud J., Moser M. Role of CD27/CD70 pathway of activation in immunity and tolerance. J Leukoc Biol 2011, 89:195-203.
52. Jacobi A.M., Mei H., Hoyer B.F., Mumtaz I.M., Thiele K., Radbruch A., et al. HLA-DRhigh/CD27high plasmablasts indicate active disease in patients with systemic lupus erythematosus. Ann Rheum Dis 2010, 69:305-308.
53. Jacobi A.M., Odendahl M., Reiter K., Bruns A., Burmester G.R., Radbruch A., et al. Correlation between circulating CD27high plasma cells and disease activity in patients with systemic lupus erythematosus. Arthritis Rheum 2003, 48:1332-1342.
54. Anolik J.H., Barnard J., Owen T., Zheng B., Kemshetti S., Looney R.J., et al. Delayed memory B cell recovery in peripheral blood and lymphoid tissue in systemic lupus erythematosus after B cell depletion therapy. Arthritis Rheum 2007, 56:3044-3056.
55. Swaak A.J., Hintzen R.Q., Huysen V., van den Brink H.G., Smeenk J.T. Serum levels of soluble forms of T cell activation antigens CD27 and CD25 in systemic lupus erythematosus in relation with lymphocytes count and disease course. Clin Rheumatol 1995, 14:293-300.
56. Font J., Pallares L., Martorell J., Martinez E., Gaya A., Vives J., et al. Elevated soluble CD27 levels in serum of patients with systemic lupus erythematosus. Clin Immunol Immunopathol 1996, 81:239-243.
57. Han B.K., White A.M., Dao K.H., Karp D.R., Wakeland E.K., Davis L.S. Increased prevalence of activated CD70+CD4+ T cells in the periphery of patients with systemic lupus erythematosus. Lupus 2005, 14:598-606.
58. Oelke K., Lu Q., Richardson D., Wu A., Deng C., Hanash S., et al. Overexpression of CD70 and overstimulation of IgG synthesis by lupus T cells and T cells treated with DNA methylation inhibitors. Arthritis Rheum 2004, 50:1850-1860.
59. Zhao M., Sun Y., Gao F., Wu X., Tang J., Yin H., et al. Epigenetics and SLE: RFX1 downregulation causes CD11a and CD70 overexpression by altering epigenetic modifications in lupus CD4+ T cells. J Autoimmun 2010, 35:58-69.
60. Yin H., Zhao M., Wu X., Gao F., Luo Y., Ma L., et al. Hypomethylation and overexpression of CD70 (TNFSF7) in CD4+ T cells of patients with primary Sjogren's syndrome. J Dermatol Sci 2010, 59:198-203.
61. Matatiele P., Tikly M., Tarr G., Gulumian M. DNA methylation similarities in genes of black South Africans with systemic lupus erythematosus and systemic sclerosis. J Biomed Sci 2015, 22:34.
62. Jiang H., Xiao R., Lian X., Kanekura T., Luo Y., Yin Y., et al. Demethylation of TNFSF7 contributes to CD70 overexpression in CD4+ T cells from patients with systemic sclerosis. Clin Immunol 2012, 143:39-44.
63. Lu Q., Wu A., Richardson B.C. Demethylation of the same promoter sequence increases CD70 expression in lupus T cells and T cells treated with lupus-inducing drugs. J Immunol 2005, 174:6212-6219.
64. Sawalha A.H., Jeffries M. Defective DNA methylation and CD70 overexpression in CD4+ T cells in MRL/lpr lupus-prone mice. Eur J Immunol 2007, 37:1407-1413.
65. Quddus J., Johnson K.J., Gavalchin J., Amento E.P., Chrisp C.E., Yung R.L., et al. Treating activated CD4+ T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to cause a lupus-like disease in syngeneic mice. J Clin Invest 1993, 92:38-53.
66. Shaw J., Wang Y.H., Ito T., Arima K., Liu Y.J. Plasmacytoid dendritic cells regulate B-cell growth and differentiation via CD70. Blood 2010, 115:3051-3057.
67. Park J.K., Han B.K., Park J.A., Woo Y.J., Kim S.Y., Lee E.Y., et al. CD70-expressing CD4 T cells produce IFN-gamma and IL-17 in rheumatoid arthritis. Rheumatology (Oxford) 2014, 53:1896-1900.
68. Lee W.W., Yang Z.Z., Li G., Weyand C.M., Goronzy J.J. Unchecked CD70 expression on T cells lowers threshold for T cell activation in rheumatoid arthritis. J Immunol 2007, 179:2609-2615.
69. Oflazoglu E., Boursalian T.E., Zeng W., Edwards A.C., Duniho S., McEarchern J.A., et al. Blocking of CD27-CD70 pathway by anti-CD70 antibody ameliorates joint disease in murine collagen-induced arthritis. J Immunol 2009, 183:3770-3777.
70. Atarashi K., Nishimura J., Shima T., Umesaki Y., Yamamoto M., Onoue M., et al. ATP drives lamina propria T(H)17 cell differentiation. Nature 2008, 455:808-812.
71. Manocha M., Rietdijk S., Laouar A., Liao G., Bhan A., Borst J., et al. Blocking CD27-CD70 costimulatory pathway suppresses experimental colitis. J Immunol 2009, 183:270-276.
72. Nakajima A., Oshima H., Nohara C., Morimoto S., Yoshino S., Kobata T., et al. Involvement of CD70-CD27 interactions in the induction of experimental autoimmune encephalomyelitis. J Neuroimmunol 2000, 109:188-196.
73. Francosalinas G., Cantaert T., Nolte M.A., Tak P.P., van Lier R.A., Baeten D.L. Enhanced costimulation by CD70+ B cells aggravates experimental autoimmune encephalomyelitis in autoimmune mice. J Neuroimmunol 2013, 255:8-17.
74. Komori M, Blake A, Greenwood M, Lin YC, Kosa P, Ghazali D, et al. Cerebrospinal fluid markers reveal intrathecal inflammation in progressive multiple sclerosis. Ann Neurol 78, 2015, 3-20.
75. Sheng Y., Jin X., Xu J., Gao J., Du X., Duan D., et al. Sequencing-based approach identified three new susceptibility loci for psoriasis. Nat Commun 2014, 5:4331.
76. De Rie M.A., Cairo I., Van Lier R.A., Bos J.D. Expression of the T-cell activation antigens CD27 and CD28 in normal and psoriatic skin. Clin Exp Dermatol 1996, 21:104-111.
77. De Rie M.A., Zonneveld I.M., Witkamp L., Van Lier R.A., Out T.A., Bos J.D. Soluble interleukin-receptor (sIL-2R) is a marker of disease activity in psoriasis: a comparison of sIL-2R, sCD27, sCD4, sCD8 and sICAM-1. Acta Derm Venereol 1996, 76:357-360.